Growth Metrics

Innoviva (INVA) Other Operating Expenses (2018 - 2025)

Innoviva (INVA) has disclosed Other Operating Expenses for 8 consecutive years, with $16.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses fell 74.22% year-over-year to $16.6 million, compared with a TTM value of $16.6 million through Dec 2025, down 74.22%, and an annual FY2022 reading of -$60.6 million, up 13.67% over the prior year.
  • Other Operating Expenses was $16.6 million for Q3 2025 at Innoviva, down from $64.6 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $64.6 million in Q3 2024 and bottomed at -$278.4 million in Q3 2022.
  • Average Other Operating Expenses over 5 years is -$27.7 million, with a median of $16.6 million recorded in 2025.
  • The sharpest move saw Other Operating Expenses plummeted 158.02% in 2022, then skyrocketed 181.86% in 2024.
  • Year by year, Other Operating Expenses stood at -$107.9 million in 2021, then plummeted by 158.02% to -$278.4 million in 2022, then surged by 71.66% to -$78.9 million in 2023, then surged by 181.86% to $64.6 million in 2024, then plummeted by 74.22% to $16.6 million in 2025.
  • Business Quant data shows Other Operating Expenses for INVA at $16.6 million in Q3 2025, $64.6 million in Q3 2024, and -$78.9 million in Q3 2023.